Recommended dose of PDX given in combination with a fixed dose of 5-FU administered as a 48-hour infusion given every other week During the initial course [clinicaltrials_resource:9dfe872ae916673c63365e60c7be4786]
Maximum tolerated dose will have been exceeded when 2 patients entered at a given dose level experience specified dose-limiting toxicities in the initial cycle.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Recommended dose of PDX given in combination with a fixed dose of 5-FU administered as a 48-hour infusion given every other week During the initial course [clinicaltrials_resource:9dfe872ae916673c63365e60c7be4786]
Maximum tolerated dose will have been exceeded when 2 patients entered at a given dose level experience specified dose-limiting toxicities in the initial cycle.
Bio2RDF identifier
9dfe872ae916673c63365e60c7be4786
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9dfe872ae916673c63365e60c7be4786
measure [clinicaltrials_vocabulary:measure]
Recommended dose of PDX given ...... nfusion given every other week
time frame [clinicaltrials_vocabulary:time-frame]
During the initial course
description
Maximum tolerated dose will ha ...... xicities in the initial cycle.
identifier
clinicaltrials_resource:9dfe872ae916673c63365e60c7be4786
title
Recommended dose of PDX given ...... week During the initial course
@en
type
label
Recommended dose of PDX given ...... e872ae916673c63365e60c7be4786]
@en